| abstract |
The present invention relates to new oxazolidinones that have a part of cyclopropyl, which are effective against aerobic and anaerobic pathogens such as multiresistant staphylococci, streptococci, enterococci, and Bacteroides spp., Clostridia spp. As well as fast acid organisms such as Mycobacterium tuberculosis and other mycobacterial species. The compounds are represented by structural Formula I (see structural formula I) their enantiomer, diastereomer, or pharmaceutically acceptable salt, or ester thereof. |